当前位置:首页 - 行情中心 - 海正药业(600267) - 财务分析 - 现金流量表

海正药业

(600267)

  

流通市值:134.91亿  总市值:134.91亿
流通股本:11.80亿   总股本:11.80亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,771,642,915.882,824,279,976.5511,160,388,744.468,563,322,286.31
  收到的税费返还27,088,126.53,576,747.6112,275,558.113,156,921.23
  收到其他与经营活动有关的现金132,105,762.4759,956,036.49356,429,834.69389,705,714.36
  经营活动现金流入小计4,930,836,804.852,887,812,760.6511,529,094,137.258,966,184,921.9
  购买商品、接受劳务支付的现金1,378,456,246.64973,099,597.525,131,740,533.083,882,573,352.92
  支付给职工以及为职工支付的现金1,083,683,246.46659,366,208.671,785,937,977.631,369,853,580.84
  支付的各项税费615,911,361.57286,099,226.5817,826,210.59602,712,320.28
  支付其他与经营活动有关的现金1,020,751,549.78518,419,818.351,761,913,400.531,466,382,116.79
  经营活动现金流出小计4,098,802,404.452,436,984,851.049,497,418,121.837,321,521,370.83
  经营活动产生的现金流量净额832,034,400.4450,827,909.612,031,676,015.421,644,663,551.07
二、投资活动产生的现金流量:
  收回投资收到的现金4,250,0004,250,000--
  取得投资收益收到的现金150,000-11,544,40016,344,491.33
  处置固定资产、无形资产和其他长期资产收回的现金净额1,418,869.02313,575.4214,677,947.533,913,015.1
  处置子公司及其他营业单位收到的现金净额465,311,216.41465,311,216.41--
  收到的其他与投资活动有关的现金2,957,618.931,054,00560,017,10055,136,592.37
  投资活动现金流入小计474,087,704.36470,928,796.8386,239,447.5375,394,098.8
  购建固定资产、无形资产和其他长期资产支付的现金217,979,274.31127,735,066.71376,395,257.64215,322,290.41
  投资支付的现金402,500,000-78,284,936.6555,784,936.65
  支付其他与投资活动有关的现金139,088,064.8138,367,752.87660,0002,960,022.35
  投资活动现金流出小计759,567,339.11266,102,819.58455,340,194.29274,067,249.41
  投资活动产生的现金流量净额-285,479,634.75204,825,977.25-369,100,746.76-198,673,150.61
三、筹资活动产生的现金流量:
  吸收投资收到的现金10,800,000---
  其中:子公司吸收少数股东投资收到的现金10,800,000---
  取得借款收到的现金881,000,000741,000,0002,357,854,777.041,431,330,849.25
  筹资活动现金流入小计891,800,000741,000,0002,357,854,777.041,431,330,849.25
  偿还债务支付的现金1,333,978,730767,178,7303,558,356,912.962,292,217,796
  分配股利、利润或偿付利息支付的现金269,730,296.1114,605,856.13343,424,482.78323,720,682.87
  支付其他与筹资活动有关的现金41,249,099.9435,892,040.1989,461,043.4259,018,938.59
  筹资活动现金流出小计1,644,958,126.05817,676,626.323,991,242,439.162,674,957,417.46
  筹资活动产生的现金流量净额-753,158,126.05-76,676,626.32-1,633,387,662.12-1,243,626,568.21
四、汇率变动对现金及现金等价物的影响-3,846,826.12-1,508,819.97-887,015.79231,228.83
五、现金及现金等价物净增加额-210,450,186.52577,468,440.5728,300,590.75202,595,061.08
  加:期初现金及现金等价物余额1,218,184,997.461,218,184,997.461,189,884,406.711,189,884,406.7
  期末现金及现金等价物余额1,007,734,810.941,795,653,438.031,218,184,997.461,392,479,467.78
补充资料:
  净利润641,713,626.28-547,485,702.43-
  资产减值准备79,751,159.13-213,171,765.88-
  固定资产和投资性房地产折旧406,626,030.32-839,605,626.49-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧406,626,030.32-839,605,626.49-
  无形资产摊销52,681,111.72-119,836,009.25-
  长期待摊费用摊销1,713,998.8-2,950,260.29-
  处置固定资产、无形资产和其他长期资产的损失-849,833.5--5,234,365.98-
  固定资产报废损失3,279,204.99-2,619,979.32-
  公允价值变动损失1,161,748.71-34,782,686.47-
  财务费用36,549,017.53-102,918,776.73-
  投资损失-176,467,593.72-34,724,323.36-
  递延所得税20,245,299.72-28,719,719.04-
  其中:递延所得税资产减少20,429,928.23-28,898,364.59-
    递延所得税负债增加-184,628.51--178,645.55-
  存货的减少318,878,634.58-66,089,346.39-
  经营性应收项目的减少-210,613,710.36-33,090,521.08-
  经营性应付项目的增加-366,251,194.05--59,352,548.42-
  其他108,965.96-512,982.57-
  现金的期末余额1,007,734,810.94-1,218,184,997.46-
  减:现金的期初余额1,218,184,997.46-1,189,884,406.71-
  现金及现金等价物的净增加额-210,450,186.52-28,300,590.75-
公告日期2026-08-262026-04-282026-04-082025-10-28
审计意见(境内)标准无保留意见
TOP↑